Stocktoria
Organogenesis Holdings Inc. ORGO
Organogenesis Holdings Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $564.2M | $482.0M | $433.1M | $450.9M | $467.4M | $338.3M | $261.0M | $193.4M | $198.5M | $138.7M |
| Gross profit | — | $366.3M | $326.7M | $345.9M | $353.2M | $251.0M | $185.0M | $124.6M | $137.3M | $90.5M |
| R&D expense | $44.5M | $50.3M | $44.4M | $39.8M | $30.7M | $20.1M | $14.8M | $10.7M | $9.1M | $6.3M |
| SG&A expense | $326.2M | $294.5M | $269.8M | $283.8M | $250.2M | $204.2M | $200.1M | $162.0M | $133.7M | $93.0M |
| Operating income | $44.7M | -$1.3M | $12.5M | $22.3M | $72.2M | $26.7M | -$29.9M | -$51.6M | -$5.5M | -$8.8M |
| Interest expense | — | — | $2.2M | $2.0M | $7.2M | $11.3M | $9.0M | $10.8M | $8.0M | $5.6M |
| Income tax | $9.9M | -$3.7M | $5.4M | $4.8M | -$31.1M | $530,000 | $150,000 | $84,000 | -$7.0M | $65,000 |
| Net income | $37.0M | $861,000 | $4.9M | $15.5M | $94.2M | $17.2M | -$38.7M | -$64.8M | -$8.4M | -$17.0M |
| EPS (diluted) | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 | $0.15 | $-0.42 | $-0.94 | — | — |
| Operating cash flow | -$10.3M | $14.2M | $30.9M | $24.9M | $62.0M | $5.5M | -$33.5M | -$60.6M | -$3.5M | -$4.9M |
| Free cash flow | -$24.5M | $4.2M | $6.6M | -$9.0M | $30.8M | -$12.2M | -$39.5M | -$62.5M | -$5.9M | -$6.2M |
| Cash & equivalents | $93.7M | $135.6M | $103.8M | $102.5M | $113.9M | $84.4M | — | — | — | — |
| Inventory | $29.6M | $26.2M | $28.3M | $24.8M | $25.0M | $27.8M | $22.9M | $13.3M | $14.3M | — |
| Total assets | $598.7M | $497.9M | $460.0M | $449.4M | $443.3M | $290.2M | $220.7M | $163.7M | $148.7M | $311.4M |
| Total liabilities | $164.8M | $112.6M | $181.4M | $183.7M | $201.9M | $148.4M | $165.1M | $116.6M | $157.3M | $11.3M |
| Shareholders' equity | $300.1M | $262.9M | $278.7M | $265.7M | $241.3M | $141.8M | $55.6M | $47.0M | -$15.3M | -$16.0M |
Growth · year-over-year · Revenue CAGR 16.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +17.0% | +11.3% | -3.9% | -3.5% | +38.2% | +29.6% | +34.9% | -2.5% | +43.1% | — |
| Net income growth | +4201.0% | -82.6% | -68.2% | -83.5% | +446.6% | — | — | — | — | — |
| EPS growth | — | -125.0% | -66.7% | -82.9% | +366.7% | — | — | — | — | — |
| Free cash flow growth | -685.7% | -36.3% | — | -129.4% | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.